ZA914520B - Hybrid plasminogen activators - Google Patents

Hybrid plasminogen activators

Info

Publication number
ZA914520B
ZA914520B ZA914520A ZA914520A ZA914520B ZA 914520 B ZA914520 B ZA 914520B ZA 914520 A ZA914520 A ZA 914520A ZA 914520 A ZA914520 A ZA 914520A ZA 914520 B ZA914520 B ZA 914520B
Authority
ZA
South Africa
Prior art keywords
plasminogen activators
hybrid plasminogen
hybrid
activators
plasminogen
Prior art date
Application number
ZA914520A
Other languages
English (en)
Inventor
Jeffery Hugh Robinson
Hugh Robinson Jeffery
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of ZA914520B publication Critical patent/ZA914520B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6435Plasmin (3.4.21.7), i.e. fibrinolysin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6456Plasminogen activators
    • C12N9/6459Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21007Plasmin (3.4.21.7), i.e. fibrinolysin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21069Protein C activated (3.4.21.69)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA914520A 1990-06-14 1991-06-12 Hybrid plasminogen activators ZA914520B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909013345A GB9013345D0 (en) 1990-06-14 1990-06-14 Novel compounds

Publications (1)

Publication Number Publication Date
ZA914520B true ZA914520B (en) 1992-12-30

Family

ID=10677652

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA914520A ZA914520B (en) 1990-06-14 1991-06-12 Hybrid plasminogen activators

Country Status (12)

Country Link
EP (1) EP0535037A1 (xx)
JP (1) JPH05506363A (xx)
KR (1) KR930701607A (xx)
AU (1) AU648567B2 (xx)
CA (1) CA2085224A1 (xx)
GB (1) GB9013345D0 (xx)
IE (1) IE911999A1 (xx)
IL (1) IL98478A0 (xx)
NZ (1) NZ238506A (xx)
PT (1) PT97983A (xx)
WO (1) WO1991019793A2 (xx)
ZA (1) ZA914520B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3888099A (en) * 1998-12-02 2000-06-19 Oklahoma Medical Research Foundation Human plasminogen activator

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ191320A (en) * 1978-09-07 1982-09-14 Beecham Group Ltd In vivo fibrinolytic enzyme having active site blocked by hydrolytically removable group pharmaceutical compositions
GB8334498D0 (en) * 1983-12-24 1984-02-01 Beecham Group Plc Compounds
DK359888A (da) * 1987-07-01 1989-01-02 Beecham Group Plc Fibrinolytisk enzym
GB9019120D0 (en) * 1990-09-01 1990-10-17 Beecham Group Plc Novel compounds

Also Published As

Publication number Publication date
NZ238506A (en) 1993-07-27
KR930701607A (ko) 1993-06-12
IE911999A1 (en) 1991-12-18
GB9013345D0 (en) 1990-08-08
PT97983A (pt) 1992-04-30
WO1991019793A3 (en) 1992-01-23
JPH05506363A (ja) 1993-09-22
AU648567B2 (en) 1994-04-28
IL98478A0 (en) 1992-07-15
EP0535037A1 (en) 1993-04-07
AU8068191A (en) 1992-01-07
CA2085224A1 (en) 1991-12-15
WO1991019793A2 (en) 1991-12-26

Similar Documents

Publication Publication Date Title
GB2246209B (en) Workpiece manufacture
HK1013589A1 (en) Headphone
TW391614U (en) Headphone set
GB2249104B (en) Bleach activators
EP0538459A4 (en) Phospholipid-targeted thrombolytic agents
AU7874591A (en) Hybrid plasminogen activator mutants
EP0458170A3 (en) Chuck
HK1000749A1 (en) Amplifier having two operating modes
GB2285796B (en) Construction Machine
GB2271756B (en) Bags
EP0297882A3 (en) Hybrid plasminogen activators
GB9325291D0 (en) Spindle
GB8721023D0 (en) Modified plasminogen activators
AU8442291A (en) Hybrid plasminogen activators
GB2241318B (en) Torch
EP0407778A3 (en) Hybrid amplifier
GB9015832D0 (en) Introducing means
ZA914520B (en) Hybrid plasminogen activators
ZA879286B (en) New plasminogen activators
GB9022999D0 (en) Bleach activators
GB9301388D0 (en) Lathe
GB9201305D0 (en) Yieldable supports
GB2262020B (en) Mounder machine
IE882684L (en) Modified plasminogen activators
IE901315L (en) Mocification of plasminogen activators